Feltl & Co Downgrades NxStage Medical (NXTM) to Hold
Tweet
Share
E-mailGet Alerts NXTM Hot Sheet
Price: $30.00 --0%
Rating Summary:
5 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 8
Rating Summary:
5 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 8
Join SI Premium – FREE
Feltl & Co downgraded NxStage Medical (NASDAQ: NXTM) shares from Buy to Hold Tuesday morning. The firm's price target was lowered from $24 to $22.
NxStage shares are down 1.8 percent to $20.50 at last check.
For an analyst ratings summary and ratings history on NxStage Medical click here. For more ratings news on NxStage Medical click here.
NxStage shares are down 1.8 percent to $20.50 at last check.
For an analyst ratings summary and ratings history on NxStage Medical click here. For more ratings news on NxStage Medical click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Downgrades PolyPeptide Group AG (PPGN:SW) to Hold
- Citi Downgrades FANUC Corp (6954:JP) (FANUY) to Neutral
- Raymond James Downgrades Abercrombie & Fitch (ANF) to Market Perform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
